Hypera - Public Comps and Valuation Multiples

Hypera Overview

About Hypera

Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and the Non-Retail Market.

Founded

2001

HQ

Employees

10.5K+

Website

hypermarcas.com.br

Sectors

Biopharmaceuticals
Drug Development & Therapeutics
BioTech

Financials

LTM Revenue $1.4B

LTM EBITDA $384M

EV

$3.9B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Hypera Financials

As of September 2025, Hypera reported last 12-month revenue of $1.4B and EBITDA of $384M.

In the same period, Hypera generated $831M in LTM gross profit and $212M in net income.

See Hypera valuation multiples based on analyst estimates

Hypera P&L

In the most recent fiscal year, Hypera reported revenue of $1.4B and EBITDA of $408M.

Hypera expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Hypera valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$1.4B	XXX	$1.4B	XXX	XXX	XXX
Gross Profit	$831M	XXX	$801M	XXX	XXX	XXX
Gross Margin	59%	XXX	59%	XXX	XXX	XXX
EBITDA	$384M	XXX	$408M	XXX	XXX	XXX
EBITDA Margin	27%	XXX	30%	XXX	XXX	XXX
EBIT	$328M	XXX	$328M	XXX	XXX	XXX
EBIT Margin	23%	XXX	24%	XXX	XXX	XXX
Net Profit	$212M	XXX	$245M	XXX	XXX	XXX
Net Margin	15%	XXX	18%	XXX	XXX	XXX
Net Debt	XXX	XXX	$1.4B	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Hypera including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $1.4B. EBITDA for the last twelve months was $384M. In the most recent fiscal year, Hypera achieved $1.4B in revenue and $408M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$1.4B	Analyst estimates available to subscribers	$1.4B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$831M	Analyst estimates available to subscribers	$801M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	59.0% gross margin	Analyst estimates available to subscribers	58.9% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$384M	Analyst estimates available to subscribers	$408M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	27.2% EBITDA margin	Analyst estimates available to subscribers	30.0% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$328M	Analyst estimates available to subscribers	$328M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	23.3% EBIT margin	Analyst estimates available to subscribers	24.1% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$212M	Analyst estimates available to subscribers	$245M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	15.1% net profit margin	Analyst estimates available to subscribers	18.0% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$1.4B	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Hypera

This financial data table provides comprehensive performance metrics for Hypera, a company based in Brazil. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Hypera generated $1.4B in revenue over the last twelve months.
The company achieved $384M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $831M.
Net income over the last twelve months reached $212M.

Fiscal Year Performance

In the most recent fiscal year, Hypera reported $1.4B in total revenue.
Fiscal year EBITDA was $408M.
The company maintained a gross profit margin of 58.9% in the most recent fiscal year.
EBITDA margin for the fiscal year was 30.0%.
Net profit margin reached 18.0% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Hypera. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Hypera Stock Performance

Hypera has current market cap of BRL 13.9B (or $2.5B), and EV of BRL 21.5B (or $3.9B).

Market Cap Evolution

Hypera Stock Data

As of October 17, 2025, Hypera's stock price is BRL 22 (or $4).

See Hypera trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$3.9B	$2.5B	XXX	XXX	XXX	XXX	$0.33

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Hypera Valuation Multiples

Hypera's trades at 2.9x EV/Revenue multiple, and 9.7x EV/EBITDA.

See valuation multiples for Hypera and 15K+ public comps

Hypera Financial Valuation Multiples

As of October 17, 2025, Hypera has market cap of $2.5B and EV of $3.9B.

Equity research analysts estimate Hypera's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Hypera has a P/E ratio of 12.0x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$2.5B	XXX	$2.5B	XXX	XXX	XXX
EV (current)	$3.9B	XXX	$3.9B	XXX	XXX	XXX
EV/Revenue	2.8x	XXX	2.9x	XXX	XXX	XXX
EV/EBITDA	10.3x	XXX	9.7x	XXX	XXX	XXX
EV/EBIT	12.0x	XXX	12.0x	XXX	XXX	XXX
EV/Gross Profit	4.7x	XXX	n/a	XXX	XXX	XXX
P/E	12.0x	XXX	10.4x	XXX	XXX	XXX
EV/FCF	13.3x	XXX	12.2x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Hypera Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Hypera Margins & Growth Rates

Hypera's last 12 month revenue growth is 18%

Hypera's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $45K for the same period.

Hypera's rule of 40 is 54% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Hypera's rule of X is 71% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Hypera and other 15K+ public comps

Hypera Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	18%	XXX	12%	XXX	XXX	XXX
EBITDA Margin	27%	XXX	30%	XXX	XXX	XXX
EBITDA Growth	39%	XXX	-15%	XXX	XXX	XXX
Rule of 40	54%	XXX	47%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	71%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$45K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	27%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	35%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial